SampleID	PrepBatch	Tech	Project	CellLine	Species	Genotype	Treatment1	Treatment2	Time_hr	LibraryPrepKit	LibraryPrepLot	LibInputSampleType	Input_ng	SpikeIn	InputWellLocation	KAPAAdapter	Index_1_i7	Index_2_i5	TagSeq_TagRead	PCRCycles	FinalBeadSelectionRatio	ElutionVolume_uL	DateQC	QubitConc_nguL	Yield_ng	Peak_ModeSize_bp	ModeMolarity_nM	Region_MeanSize_bp	MeanMolarity_nM	DateSubmission	NumberReadsRequested	PE_or_SE	ReadLength	DateSeqReceived	SeqBatch	Lane	PF_Clusters	Percent_Lane	Percent_PerfectBarcode	Percent_OneMismatchBarcode	Yield_Mbases	Percent_PF_Clusters	Percent_GreaterThanEqualToQ30_Bases	MeanQualityScore	Comments
NM2019_0001	20190402	AB	STEROID	H295R	human		NA	AngII	0	KAPA_RNAHyper_RiboErase	081534-1-1	TotalRNA	500	ERCC	A2	A2	TCCGGAGA	TATAGCCT	NA	10	0.8	20	20190403	22	440	360	92.6	431	77.3	20190408	4.00E+07	PE	150	20190419	190415_A00405_0091_BHK72CDSXX	2	60,768,976	2.43	97.39	2.61	18,352	100	88.17	34.83	
NM2019_0002	20190402	AB	STEROID	H295R	human		NA	AngII	0.25	KAPA_RNAHyper_RiboErase	081534-1-1	TotalRNA	500	ERCC	B2	B2	TCCGGAGA	ATAGAGGC	NA	10	0.8	20	20190403	23.8	476	374	96.4	439	82.1	20190408	4.00E+07	PE	150	20190419	190415_A00405_0091_BHK72CDSXX	2	84,932,035	3.4	97.16	2.84	25,649	100	88.6	34.94	
NM2019_0003	20190402	AB	STEROID	H295R	human		NA	AngII	0.5	KAPA_RNAHyper_RiboErase	081534-1-1	TotalRNA	500	ERCC	C2	C2	TCCGGAGA	CCTATCCT	NA	10	0.8	20	20190403	28.2	564	381	112.1	446	95.8	20190408	4.00E+07	PE	150	20190419	190415_A00405_0091_BHK72CDSXX	2	47,821,086	1.91	96.97	3.03	14,442	100	88.69	34.96	
NM2019_0004	20190402	AB	STEROID	H295R	human		NA	AngII	0.75	KAPA_RNAHyper_RiboErase	081534-1-1	TotalRNA	500	ERCC	D2	D2	TCCGGAGA	GGCTCTGA	NA	10	0.8	20	20190403	34	680	374	137.7	441	116.8	20190408	4.00E+07	PE	150	20190419	190415_A00405_0091_BHK72CDSXX	2	66,910,324	2.68	97.11	2.89	20,207	100	88.89	35	
NM2019_0005	20190402	AB	STEROID	H295R	human		NA	AngII	1	KAPA_RNAHyper_RiboErase	081534-1-1	TotalRNA	500	ERCC	E2	E2	TCCGGAGA	AGGCGAAG	NA	10	0.8	20	20190403	22.4	448	364	93.2	421	80.6	20190408	4.00E+07	PE	150	20190419	190415_A00405_0091_BHK72CDSXX	2	53,475,168	2.14	97.24	2.76	16,150	100	88.9	35	
NM2019_0006	20190402	AB	STEROID	H295R	human		NA	AngII	1.5	KAPA_RNAHyper_RiboErase	081534-1-1	TotalRNA	500	ERCC	F2	F2	TCCGGAGA	TAATCTTA	NA	10	0.8	20	20190403	32	640	364	133.2	425	114.1	20190408	4.00E+07	PE	150	20190419	190415_A00405_0091_BHK72CDSXX	2	53,242,866	2.13	97.25	2.75	16,079	100	88.59	34.93	
NM2019_0007	20190402	AB	STEROID	H295R	human		NA	AngII	2	KAPA_RNAHyper_RiboErase	081534-1-1	TotalRNA	500	ERCC	A4	A3	CGCTCATT	TATAGCCT	NA	10	0.8	20	20190403	28	560	360	117.8	425	99.8	20190408	4.00E+07	PE	150	20190419	190415_A00405_0091_BHK72CDSXX	2	58,726,383	2.35	96.93	3.07	17,735	100	89.11	35.04	
NM2019_0008	20190402	AB	STEROID	H295R	human		NA	AngII	3	KAPA_RNAHyper_RiboErase	081534-1-1	TotalRNA	500	ERCC	B4	B3	CGCTCATT	ATAGAGGC	NA	10	0.8	20	20190403	28.6	572	358	121	415	104.4	20190408	4.00E+07	PE	150	20190419	190415_A00405_0091_BHK72CDSXX	2	74,799,167	2.99	96.81	3.19	22,589	100	89.36	35.1	
NM2019_0009	20190402	AB	STEROID	H295R	human		NA	AngII	4	KAPA_RNAHyper_RiboErase	081534-1-1	TotalRNA	500	ERCC	C4	C3	CGCTCATT	CCTATCCT	NA	10	0.8	20	20190403	33	660	374	133.7	429	116.6	20190408	4.00E+07	PE	150	20190419	190415_A00405_0091_BHK72CDSXX	2	58,957,266	2.36	96.37	3.63	17,805	100	89.44	35.12	
NM2019_0010	20190402	AB	STEROID	H295R	human		NA	AngII	6	KAPA_RNAHyper_RiboErase	081534-1-1	TotalRNA	500	ERCC	D4	D3	CGCTCATT	GGCTCTGA	NA	10	0.8	20	20190403	35.8	716	355	152.8	417	130.1	20190408	4.00E+07	PE	150	20190419	190415_A00405_0091_BHK72CDSXX	2	53,853,465	2.15	96.7	3.3	16,264	100	89.7	35.18	
NM2019_0011	20190402	AB	STEROID	H295R	human		NA	AngII	8	KAPA_RNAHyper_RiboErase	081534-1-1	TotalRNA	500	ERCC	E4	E3	CGCTCATT	AGGCGAAG	NA	10	0.8	20	20190403	27.4	548	358	116	414	100.3	20190408	4.00E+07	PE	150	20190419	190415_A00405_0091_BHK72CDSXX	2	55,649,918	2.23	96.89	3.11	16,806	100	89.68	35.17	
NM2019_0012	20190402	AB	STEROID	H295R	human		NA	AngII	24	KAPA_RNAHyper_RiboErase	081534-1-1	TotalRNA	500	ERCC	F4	F3	CGCTCATT	TAATCTTA	NA	10	0.8	20	20190403	31.6	632	349	137.2	406	117.9	20190408	4.00E+07	PE	150	20190419	190415_A00405_0091_BHK72CDSXX	2	60,392,170	2.42	96.89	3.11	18,238	100	89.27	35.08	
NM2019_0013	20190404	AB	STEROID	H295R	human		NA	AngII	0	KAPA_RNAHyper_RiboErase	081534-1-1	TotalRNA	500	ERCC	A2	A4	GAGATTCC	TATAGCCT	NA	10	0.8	20	20190405	18.5	370	369	76	440	63.7	20190408	4.00E+07	PE	150	20190419	190415_A00405_0091_BHK72CDSXX	2	41,375,619	1.65	96.72	3.28	12,495	100	89.57	35.14	
NM2019_0014	20190404	AB	STEROID	H295R	human		NA	AngII	0.25	KAPA_RNAHyper_RiboErase	081534-1-1	TotalRNA	500	ERCC	B2	B4	GAGATTCC	ATAGAGGC	NA	10	0.8	20	20190405	19.4	388	358	82.1	434	67.7	20190408	4.00E+07	PE	150	20190419	190415_A00405_0091_BHK72CDSXX	2	52,392,675	2.1	96.62	3.38	15,823	100	89.78	35.19	
NM2019_0015	20190404	AB	STEROID	H295R	human		NA	AngII	0.5	KAPA_RNAHyper_RiboErase	081534-1-1	TotalRNA	500	ERCC	C2	C4	GAGATTCC	CCTATCCT	NA	10	0.8	20	20190405	24	480	373	97.5	440	82.6	20190408	4.00E+07	PE	150	20190419	190415_A00405_0091_BHK72CDSXX	2	42,619,509	1.7	96	4	12,871	100	89.79	35.19	
NM2019_0016	20190404	AB	STEROID	H295R	human		NA	AngII	0.75	KAPA_RNAHyper_RiboErase	081534-1-1	TotalRNA	500	ERCC	D2	D4	GAGATTCC	GGCTCTGA	NA	10	0.8	20	20190405	24	480	380	95.7	438	83	20190408	4.00E+07	PE	150	20190419	190415_A00405_0091_BHK72CDSXX	2	40,105,500	1.6	96.38	3.62	12,112	100	89.99	35.24	
NM2019_0017	20190404	AB	STEROID	H295R	human		NA	AngII	1	KAPA_RNAHyper_RiboErase	081534-1-1	TotalRNA	500	ERCC	E2	E4	GAGATTCC	AGGCGAAG	NA	10	0.8	20	20190405	15.3	306	373	62.1	432	53.7	20190408	4.00E+07	PE	150	20190419	190415_A00405_0091_BHK72CDSXX	2	42,328,867	1.69	96.72	3.28	12,783	100	90.07	35.25	
NM2019_0018	20190404	AB	STEROID	H295R	human		NA	AngII	1.5	KAPA_RNAHyper_RiboErase	081534-1-1	TotalRNA	500	ERCC	F2	F4	GAGATTCC	TAATCTTA	NA	10	0.8	20	20190405	20.2	404	370	82.7	430	71.2	20190408	4.00E+07	PE	150	20190419	190415_A00405_0091_BHK72CDSXX	2	47,315,165	1.89	96.56	3.44	14,289	100	89.8	35.19	
NM2019_0019	20190404	AB	STEROID	H295R	human		NA	AngII	2	KAPA_RNAHyper_RiboErase	081534-1-1	TotalRNA	500	ERCC	A4	A5	ATTCAGAA	TATAGCCT	NA	10	0.8	20	20190405	18.7	374	369	76.8	427	66.4	20190408	4.00E+07	PE	150	20190419	190415_A00405_0091_BHK72CDSXX	2	44,661,451	1.79	96.98	3.02	13,488	100	88.88	35	
NM2019_0020	20190404	AB	STEROID	H295R	human		NA	AngII	3	KAPA_RNAHyper_RiboErase	081534-1-1	TotalRNA	500	ERCC	B4	B5	ATTCAGAA	ATAGAGGC	NA	10	0.8	20	20190405	17.8	356	355	76	419	64.4	20190408	4.00E+07	PE	150	20190419	190415_A00405_0091_BHK72CDSXX	2	50,977,270	2.04	96.79	3.21	15,395	100	89.28	35.09	
NM2019_0021	20190404	AB	STEROID	H295R	human		NA	AngII	4	KAPA_RNAHyper_RiboErase	081534-1-1	TotalRNA	500	ERCC	C4	C5	ATTCAGAA	CCTATCCT	NA	10	0.8	20	20190405	18.4	368	360	77.4	419	66.5	20190408	4.00E+07	PE	150	20190419	190415_A00405_0091_BHK72CDSXX	2	38,828,135	1.55	96.47	3.53	11,726	100	89.12	35.05	
NM2019_0022	20190404	AB	STEROID	H295R	human		NA	AngII	6	KAPA_RNAHyper_RiboErase	081534-1-1	TotalRNA	500	ERCC	D4	D5	ATTCAGAA	GGCTCTGA	NA	10	0.8	20	20190405	21.2	424	367	87.5	435	73.8	20190408	4.00E+07	PE	150	20190419	190415_A00405_0091_BHK72CDSXX	2	41,458,473	1.66	96.92	3.08	12,520	100	89.39	35.11	
NM2019_0023	20190404	AB	STEROID	H295R	human		NA	AngII	8	KAPA_RNAHyper_RiboErase	081534-1-1	TotalRNA	500	ERCC	E4	E5	ATTCAGAA	AGGCGAAG	NA	10	0.8	20	20190405	15.7	314	389	61.2	438	54.3	20190408	4.00E+07	PE	150	20190419	190415_A00405_0091_BHK72CDSXX	2	40,865,079	1.63	96.85	3.15	12,341	100	89.57	35.15	
NM2019_0024	20190404	AB	STEROID	H295R	human		NA	AngII	24	KAPA_RNAHyper_RiboErase	081534-1-1	TotalRNA	500	ERCC	F4	F5	ATTCAGAA	TAATCTTA	NA	10	0.8	20	20190405	21	420	359	88.6	413	77	20190408	4.00E+07	PE	150	20190419	190415_A00405_0091_BHK72CDSXX	2	45,580,606	1.82	96.93	3.07	13,765	100	89.11	35.05	
NM2019_0035	20190802	AB	Rainey	PrimaryAdrenal_DAN32	human		basal	Sample1	3	KAPA_RNAHyper	102449-1-1	LexogenPolyA	60.8	NA	A1	A4	GAGATTCC	TATAGCCT	NA	15	0.8	25	20190802	9.26	231.5	360	39	449	31.2	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	23,214,881	0.79	97.33	2.67	7,011	100	90.98	35.41	
NM2019_0036	20190802	AB	Rainey	PrimaryAdrenal_DAN32	human		basal	Sample2	3	KAPA_RNAHyper	102449-1-1	LexogenPolyA	56	NA	B1	B4	GAGATTCC	ATAGAGGC	NA	15	0.8	25	20190802	3.76	94	356	16	436	13.1	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	29,180,730	1	96.8	3.2	8,813	100	91.25	35.47	
NM2019_0037	20190802	AB	Rainey	PrimaryAdrenal_DAN32	human		basal	Sample3	3	KAPA_RNAHyper	102449-1-1	LexogenPolyA	79.2	NA	C1	C4	GAGATTCC	CCTATCCT	NA	15	0.8	25	20190802	14.8	370	405	55.4	466	48.1	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	22,998,897	0.79	96.26	3.74	6,946	100	91.39	35.51	
NM2019_0038	20190802	AB	Rainey	PrimaryAdrenal_DAN32	human		AngII	Sample4	3	KAPA_RNAHyper	102449-1-1	LexogenPolyA	42.4	NA	D1	D4	GAGATTCC	GGCTCTGA	NA	15	0.8	25	20190802	8.64	216	395	33.1	458	28.6	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	20,880,953	0.71	96.02	3.98	6,306	100	91.48	35.53	
NM2019_0039	20190802	AB	Rainey	PrimaryAdrenal_DAN32	human		AngII	Sample5	3	KAPA_RNAHyper	102449-1-1	LexogenPolyA	44	NA	E1	E4	GAGATTCC	AGGCGAAG	NA	15	0.8	25	20190802	3.26	81.5	415	11.9	465	10.6	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	23,561,442	0.8	96.43	3.57	7,116	100	91.43	35.51	
NM2019_0040	20190802	AB	Rainey	PrimaryAdrenal_DAN32	human		AngII	Sample6	3	KAPA_RNAHyper	102449-1-1	LexogenPolyA	64	NA	F1	F4	GAGATTCC	TAATCTTA	NA	15	0.8	25	20190802	8.92	223	366	36.9	446	30.3	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	25,506,202	0.87	97.23	2.77	7,703	100	91.09	35.44	
NM2019_0041	20190802	AB	Rainey	PrimaryAdrenal_DAN32	human		ACTH	Sample7	3	KAPA_RNAHyper	102449-1-1	LexogenPolyA	45.6	NA	G1	G4	GAGATTCC	CAGGACGT	NA	15	0.8	25	20190802	6.34	158.5	364	26.4	440	21.8	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	24,823,627	0.85	96.89	3.11	7,497	100	91.29	35.48	
NM2019_0042	20190802	AB	Rainey	PrimaryAdrenal_DAN32	human		ACTH	Sample8	3	KAPA_RNAHyper	102449-1-1	LexogenPolyA	44.8	NA	H1	H4	GAGATTCC	GTACTGAC	NA	15	0.8	25	20190802	10.6	265	367	43.8	445	36.1	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	22,972,793	0.78	96.01	3.99	6,938	100	91.37	35.51	
NM2019_0043	20190802	AB	Rainey	PrimaryAdrenal_DAN32	human		ACTH	Sample9	3	KAPA_RNAHyper	102449-1-1	LexogenPolyA	70.4	NA	A2	A5	ATTCAGAA	TATAGCCT	NA	15	0.8	25	20190802	11.1	277.5	385	43.7	463	36.3	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	25,060,361	0.86	97.54	2.46	7,568	100	90.61	35.34	
NM2019_0044	20190802	AB	Rainey	PrimaryAdrenal_DAN32	human		basal	Sample10	6	KAPA_RNAHyper	102449-1-1	LexogenPolyA	49.6	NA	B2	B5	ATTCAGAA	ATAGAGGC	NA	15	0.8	25	20190802	8.96	224	405	33.5	476	28.5	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	26,756,016	0.91	96.83	3.17	8,080	100	90.94	35.41	
NM2019_0045	20190802	AB	Rainey	PrimaryAdrenal_DAN32	human		basal	Sample11	6	KAPA_RNAHyper	102449-1-1	LexogenPolyA	45.6	NA	C2	C5	ATTCAGAA	CCTATCCT	NA	15	0.8	25	20190802	8.8	220	412	32.4	473	28.2	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	24,240,864	0.83	96.4	3.6	7,321	100	91	35.42	
NM2019_0046	20190802	AB	Rainey	PrimaryAdrenal_DAN32	human		basal	Sample12	6	KAPA_RNAHyper	102449-1-1	LexogenPolyA	52.8	NA	D2	D5	ATTCAGAA	GGCTCTGA	NA	15	0.8	25	20190802	14.6	365	405	54.6	468	47.3	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	24,327,739	0.83	96.83	3.17	7,347	100	91.1	35.45	
NM2019_0047	20190802	AB	Rainey	PrimaryAdrenal_DAN32	human		AngII	Sample13	6	KAPA_RNAHyper	102449-1-1	LexogenPolyA	60.8	NA	E2	E5	ATTCAGAA	AGGCGAAG	NA	15	0.8	25	20190802	11.3	282.5	400	42.8	471	36.4	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	24,509,245	0.84	96.67	3.33	7,402	100	91.16	35.46	
NM2019_0048	20190802	AB	Rainey	PrimaryAdrenal_DAN32	human		AngII	Sample14	6	KAPA_RNAHyper	102449-1-1	LexogenPolyA	48.8	NA	F2	F5	ATTCAGAA	TAATCTTA	NA	15	0.8	25	20190802	16.7	417.5	406	62.3	479	52.8	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	24,902,718	0.85	97.24	2.76	7,521	100	90.65	35.35	
NM2019_0049	20190802	AB	Rainey	PrimaryAdrenal_DAN32	human		AngII	Sample15	6	KAPA_RNAHyper	102449-1-1	LexogenPolyA	56.8	NA	G2	G5	ATTCAGAA	CAGGACGT	NA	15	0.8	25	20190802	15.4	385	384	60.8	462	50.5	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	28,218,945	0.96	97.17	2.83	8,522	100	90.9	35.4	
NM2019_0050	20190802	AB	Rainey	PrimaryAdrenal_DAN32	human		ACTH	Sample16	6	KAPA_RNAHyper	102449-1-1	LexogenPolyA	56.8	NA	H2	H5	ATTCAGAA	GTACTGAC	NA	15	0.8	25	20190802	24.4	610	365	101.3	457	80.9	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	25,737,142	0.88	96.2	3.8	7,773	100	90.93	35.42	
NM2019_0051	20190802	AB	Rainey	PrimaryAdrenal_DAN32	human		ACTH	Sample17	6	KAPA_RNAHyper	102449-1-1	LexogenPolyA	53.6	NA	A3	A6	GAATTCGT	TATAGCCT	NA	15	0.8	25	20190802	9.2	230	350	39.8	437	31.9	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	29,724,694	1.01	97.46	2.54	8,977	100	90.99	35.41	
NM2019_0052	20190802	AB	Rainey	PrimaryAdrenal_DAN32	human		ACTH	Sample18	6	KAPA_RNAHyper	102449-1-1	LexogenPolyA	52	NA	B3	B6	GAATTCGT	ATAGAGGC	NA	15	0.8	25	20190802	9.38	234.5	404	35.2	470	30.2	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	30,365,916	1.04	96.89	3.11	9,171	100	91.26	35.47	
NM2019_0053	20190802	AB	Rainey	PrimaryAdrenal_DAN32	human		basal	Sample19	12	KAPA_RNAHyper	102449-1-1	LexogenPolyA	55.2	NA	C3	C6	GAATTCGT	CCTATCCT	NA	15	0.8	25	20190802	15.5	387.5	428	54.9	483	48.6	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	27,416,439	0.94	96.71	3.29	8,280	100	91.33	35.49	
NM2019_0054	20190802	AB	Rainey	PrimaryAdrenal_DAN32	human		basal	Sample20	12	KAPA_RNAHyper	102449-1-1	LexogenPolyA	68	NA	D3	D6	GAATTCGT	GGCTCTGA	NA	15	0.8	25	20190802	15.5	387.5	427	55	484	48.5	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	24,371,711	0.83	96.56	3.44	7,360	100	91.47	35.52	
NM2019_0055	20190802	AB	Rainey	PrimaryAdrenal_DAN32	human		basal	Sample21	12	KAPA_RNAHyper	102449-1-1	LexogenPolyA	69.6	NA	E3	E6	GAATTCGT	AGGCGAAG	NA	15	0.8	25	20190802	8.8	220	416	32.1	476	28	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	26,923,330	0.92	95.85	4.15	8,131	100	91.45	35.51	
NM2019_0056	20190802	AB	Rainey	PrimaryAdrenal_DAN32	human		AngII	Sample22	12	KAPA_RNAHyper	102449-1-1	LexogenPolyA	61.6	NA	F3	F6	GAATTCGT	TAATCTTA	NA	15	0.8	25	20190802	17.1	427.5	419	61.8	481	53.9	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	27,911,565	0.95	97.21	2.79	8,429	100	91	35.42	
NM2019_0057	20190802	AB	Rainey	PrimaryAdrenal_DAN32	human		AngII	Sample23	12	KAPA_RNAHyper	102449-1-1	LexogenPolyA	81.6	NA	G3	G6	GAATTCGT	CAGGACGT	NA	15	0.8	25	20190802	3.16	79	362	13.2	431	11.1	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	29,228,138	1	97.04	2.96	8,827	100	90.98	35.4	
NM2019_0058	20190802	AB	Rainey	PrimaryAdrenal_DAN32	human		AngII	Sample24	12	KAPA_RNAHyper	102449-1-1	LexogenPolyA	48	NA	H3	H6	GAATTCGT	GTACTGAC	NA	15	0.8	25	20190802	21.6	540	381	85.9	460	71.1	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	25,868,517	0.88	96.41	3.59	7,812	100	91.3	35.48	
NM2019_0059	20190806	AB	Rainey	PrimaryAdrenal_DAN32	human		ACTH	Sample25	12	KAPA_RNAHyper	102449-1-1	LexogenPolyA	92	NA	A1	A7	CTGAAGCT	TATAGCCT	NA	15	0.8	25	20190807	48.8	1220	417	177.3	478	154.7	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	46,832,403	1.6	97.56	2.44	14,143	100	90.6	35.34	
NM2019_0060	20190806	AB	Rainey	PrimaryAdrenal_DAN32	human		ACTH	Sample26	12	KAPA_RNAHyper	102449-1-1	LexogenPolyA	88	NA	B1	B7	CTGAAGCT	ATAGAGGC	NA	15	0.8	25	20190807	38	950	434	132.7	496	116.1	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	52,956,675	1.81	96.77	3.23	15,993	100	90.86	35.4	
NM2019_0061	20190806	AB	Rainey	PrimaryAdrenal_DAN32	human		ACTH	Sample27	12	KAPA_RNAHyper	102449-1-1	LexogenPolyA	70.4	NA	C1	C7	CTGAAGCT	CCTATCCT	NA	15	0.8	25	20190807	46.4	1160	429	163.9	500	140.6	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	44,902,231	1.53	96.47	3.53	13,560	100	90.96	35.42	
NM2019_0062	20190806	AB	Rainey	PrimaryAdrenal_DAN32	human		basal	Sample28	24	KAPA_RNAHyper	102449-1-1	LexogenPolyA	88.8	NA	D1	D7	CTGAAGCT	GGCTCTGA	NA	15	0.8	25	20190807	32.4	810	418	117.4	482	101.8	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	42,860,765	1.46	96.62	3.38	12,944	100	91.03	35.44	
NM2019_0063	20190806	AB	Rainey	PrimaryAdrenal_DAN32	human		basal	Sample29	24	KAPA_RNAHyper	102449-1-1	LexogenPolyA	71.2	NA	E1	E7	CTGAAGCT	AGGCGAAG	NA	15	0.8	25	20190807	10.6	265	424	37.9	487	33	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	43,279,147	1.48	96.48	3.52	13,070	100	91.14	35.45	
NM2019_0064	20190806	AB	Rainey	PrimaryAdrenal_DAN32	human		basal	Sample30	24	KAPA_RNAHyper	102449-1-1	LexogenPolyA	59.2	NA	F1	F7	CTGAAGCT	TAATCTTA	NA	15	0.8	25	20190807	17	425	433	59.5	482	53.4	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	43,460,600	1.48	97.49	2.51	13,125	100	90.79	35.38	
NM2019_0065	20190806	AB	Rainey	PrimaryAdrenal_DAN32	human		AngII	Sample31	24	KAPA_RNAHyper	102449-1-1	LexogenPolyA	79.2	NA	G1	G7	CTGAAGCT	CAGGACGT	NA	15	0.8	25	20190807	15.4	385	418	55.8	478	48.8	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	40,751,194	1.39	97.16	2.84	12,307	100	90.88	35.39	
NM2019_0066	20190806	AB	Rainey	PrimaryAdrenal_DAN32	human		AngII	Sample32	24	KAPA_RNAHyper	102449-1-1	LexogenPolyA	84	NA	H1	H7	CTGAAGCT	GTACTGAC	NA	15	0.8	25	20190807	35.8	895	432	125.6	482	112.5	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	42,446,451	1.45	96.18	3.82	12,819	100	90.86	35.4	
NM2019_0067	20190806	AB	Rainey	PrimaryAdrenal_DAN32	human		AngII	Sample33	24	KAPA_RNAHyper	102449-1-1	LexogenPolyA	68.8	NA	A2	A8	TAATGCGC	TATAGCCT	NA	15	0.8	25	20190807	11.5	287.5	414	42.1	484	36	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	37,543,319	1.28	96.8	3.2	11,338	100	90.58	35.33	
NM2019_0068	20190806	AB	Rainey	PrimaryAdrenal_DAN32	human		ACTH	Sample34	24	KAPA_RNAHyper	102449-1-1	LexogenPolyA	69.6	NA	B2	B8	TAATGCGC	ATAGAGGC	NA	15	0.8	25	20190807	13.3	332.5	426	47.3	487	41.4	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	41,419,399	1.41	95.46	4.54	12,509	100	90.97	35.43	
NM2019_0069	20190806	AB	Rainey	PrimaryAdrenal_DAN32	human		ACTH	Sample35	24	KAPA_RNAHyper	102449-1-1	LexogenPolyA	84	NA	C2	C8	TAATGCGC	CCTATCCT	NA	15	0.8	25	20190807	29.6	740	451	99.4	504	89	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	40,391,975	1.38	95.85	4.15	12,198	100	90.96	35.42	
NM2019_0070	20190806	AB	Rainey	PrimaryAdrenal_DAN32	human		ACTH	Sample37	24	KAPA_RNAHyper	102449-1-1	LexogenPolyA	96	NA	D2	D8	TAATGCGC	GGCTCTGA	NA	15	0.8	25	20190807	31.4	785	434	109.6	492	96.7	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	35,855,979	1.22	95.76	4.24	10,829	100	91	35.43	
NM2019_0071	20190806	AB	Rainey	PrimaryAdrenal_DAN32	human		basal	Sample39	48	KAPA_RNAHyper	102449-1-1	LexogenPolyA	72	NA	E2	E8	TAATGCGC	AGGCGAAG	NA	15	0.8	25	20190807	18.7	467.5	435	65.1	494	57.4	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	37,016,679	1.26	95.9	4.1	11,179	100	91.09	35.45	
NM2019_0072	20190806	AB	Rainey	PrimaryAdrenal_DAN32	human		basal	Sample40	48	KAPA_RNAHyper	102449-1-1	LexogenPolyA	79.2	NA	F2	F8	TAATGCGC	TAATCTTA	NA	15	0.8	25	20190807	29.2	730	420	105.3	484	91.4	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	40,030,980	1.37	96.46	3.54	12,089	100	90.76	35.38	
NM2019_0073	20190806	AB	Rainey	PrimaryAdrenal_DAN32	human		basal	Sample41	48	KAPA_RNAHyper	102449-1-1	LexogenPolyA	59.2	NA	G2	G8	TAATGCGC	CAGGACGT	NA	15	0.8	25	20190807	16.6	415	436	57.7	488	51.5	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	35,824,074	1.22	96.73	3.27	10,819	100	90.81	35.38	
NM2019_0074	20190806	AB	Rainey	PrimaryAdrenal_DAN32	human		AngII	Sample42	48	KAPA_RNAHyper	102449-1-1	LexogenPolyA	73.6	NA	H2	H8	TAATGCGC	GTACTGAC	NA	15	0.8	25	20190807	45.4	1135	436	157.8	495	139	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	36,523,349	1.25	95.42	4.58	11,030	100	90.81	35.4	
NM2019_0075	20190806	AB	Rainey	PrimaryAdrenal_DAN32	human		AngII	Sample43	48	KAPA_RNAHyper	102449-1-1	LexogenPolyA	92	NA	A3	A9	CGGCTATG	TATAGCCT	NA	15	0.8	25	20190807	36.4	910	480	114.9	526	104.9	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	38,305,687	1.31	96.09	3.91	11,568	100	90.76	35.38	
NM2019_0076	20190806	AB	Rainey	PrimaryAdrenal_DAN32	human		AngII	Sample44	48	KAPA_RNAHyper	102449-1-1	LexogenPolyA	135.2	NA	B3	B9	CGGCTATG	ATAGAGGC	NA	15	0.8	25	20190807	20.8	520	453	69.6	504	62.5	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	42,989,050	1.47	95.68	4.32	12,983	100	91.03	35.43	
NM2019_0077	20190806	AB	Rainey	PrimaryAdrenal_DAN32	human		ACTH	Sample45	48	KAPA_RNAHyper	102449-1-1	LexogenPolyA	81.6	NA	C3	C9	CGGCTATG	CCTATCCT	NA	15	0.8	25	20190807	31	775	443	106	498	94.3	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	39,473,128	1.35	95.77	4.23	11,921	100	91.18	35.46	
NM2019_0078	20190806	AB	Rainey	PrimaryAdrenal_DAN32	human		ACTH	Sample46	48	KAPA_RNAHyper	102449-1-1	LexogenPolyA	56.8	NA	D3	D9	CGGCTATG	GGCTCTGA	NA	15	0.8	25	20190807	14.5	362.5	423	51.9	488	45	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	34,970,404	1.19	95.75	4.25	10,561	100	91.17	35.46	
NM2019_0079	20190806	AB	Rainey	PrimaryAdrenal_DAN32	human		ACTH	Sample47	48	KAPA_RNAHyper	102449-1-1	LexogenPolyA	79.2	NA	E3	E9	CGGCTATG	AGGCGAAG	NA	15	0.8	25	20190807	18.4	460	429	65	491	56.8	20190809	2.00E+07	PE	150	20190822	190816_A00405_0126_BHH3GFDSXX	2	40,060,452	1.37	95.74	4.26	12,098	100	91.2	35.47	